Genome Analysis and Antibiofilm Activity of Phage 590B against Multidrug-Resistant and Extensively Drug-Resistant Uropathogenic <i>Escherichia coli</i> Isolates, India

Urinary tract infections (UTIs) are among the most common bacterial infections in humans. Uropathogenic <i>Escherichia coli</i> (UPEC), which are the most frequent agents causing community as well as hospital-acquired UTIs, have become highly drug-resistant, thus making the treatment of...

Full description

Bibliographic Details
Main Authors: Naveen Chaudhary, Ravi Kumar Maurya, Dharminder Singh, Balvinder Mohan, Neelam Taneja
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/11/12/1448
_version_ 1827637382671761408
author Naveen Chaudhary
Ravi Kumar Maurya
Dharminder Singh
Balvinder Mohan
Neelam Taneja
author_facet Naveen Chaudhary
Ravi Kumar Maurya
Dharminder Singh
Balvinder Mohan
Neelam Taneja
author_sort Naveen Chaudhary
collection DOAJ
description Urinary tract infections (UTIs) are among the most common bacterial infections in humans. Uropathogenic <i>Escherichia coli</i> (UPEC), which are the most frequent agents causing community as well as hospital-acquired UTIs, have become highly drug-resistant, thus making the treatment of these infections challenging. Recently, the use of bacteriophages (or ‘phages’) against multidrug-resistant (MDR) and extensively drug-resistant (XDR) microorganisms has garnered significant global attention. Bacterial biofilms play a vital role in the pathogenesis of UTIs caused by UPEC. Phages have the potential to disrupt bacterial biofilms using lytic enzymes such as EPS depolymerases and endolysins. We isolated a lytic phage (590B) from community sewage in Chandigarh, which was active against multiple MDR and XDR biofilm-forming UPEC strains. During whole-genome sequencing, the 44.3 kb long genome of phage 590B encoded 75 ORFs, of which 40 were functionally annotated based on homology with similar phage proteins in the database. Comparative analysis of associated phage genomes indicated that phage 590B evolved independently and had a distinct taxonomic position within the genus <i>Kagunavirus</i> in the subfamily <i>Guernseyvirinae</i> of <i>Siphoviridae</i>. The phage disrupted biofilm mass effectively when applied to 24 h old biofilms formed on the Foley silicon catheter and coverslip biofilm models. To study the effect of intact biofilm architecture on phage predation, the biofilms were disrupted. The phage reduced the viable cells by 0.6–1.0 order of magnitude after 24 h of incubation. Regrowth and intact bacterial cells were observed in the phage-treated planktonic culture and biofilms, respectively, which indicated the emergence of phage-resistant bacterial variants. The phage genome encoded an endolysin which might have a role in the disruption and inhibition of bacterial biofilms. Moreover, the genome lacked genes encoding toxins, virulence factors, antibiotic resistance, or lysogeny. Therefore, lytic phage 590B may be a good alternative to antibiotics and can be included in phage cocktails for the treatment of UTIs caused by biofilm-forming MDR and XDR UPEC strains.
first_indexed 2024-03-09T15:59:18Z
format Article
id doaj.art-5e541301847a4144884540f842edc0a2
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-09T15:59:18Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-5e541301847a4144884540f842edc0a22023-11-24T17:12:53ZengMDPI AGPathogens2076-08172022-11-011112144810.3390/pathogens11121448Genome Analysis and Antibiofilm Activity of Phage 590B against Multidrug-Resistant and Extensively Drug-Resistant Uropathogenic <i>Escherichia coli</i> Isolates, IndiaNaveen Chaudhary0Ravi Kumar Maurya1Dharminder Singh2Balvinder Mohan3Neelam Taneja4Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, IndiaDepartment of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, IndiaDepartment of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, IndiaDepartment of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, IndiaDepartment of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, IndiaUrinary tract infections (UTIs) are among the most common bacterial infections in humans. Uropathogenic <i>Escherichia coli</i> (UPEC), which are the most frequent agents causing community as well as hospital-acquired UTIs, have become highly drug-resistant, thus making the treatment of these infections challenging. Recently, the use of bacteriophages (or ‘phages’) against multidrug-resistant (MDR) and extensively drug-resistant (XDR) microorganisms has garnered significant global attention. Bacterial biofilms play a vital role in the pathogenesis of UTIs caused by UPEC. Phages have the potential to disrupt bacterial biofilms using lytic enzymes such as EPS depolymerases and endolysins. We isolated a lytic phage (590B) from community sewage in Chandigarh, which was active against multiple MDR and XDR biofilm-forming UPEC strains. During whole-genome sequencing, the 44.3 kb long genome of phage 590B encoded 75 ORFs, of which 40 were functionally annotated based on homology with similar phage proteins in the database. Comparative analysis of associated phage genomes indicated that phage 590B evolved independently and had a distinct taxonomic position within the genus <i>Kagunavirus</i> in the subfamily <i>Guernseyvirinae</i> of <i>Siphoviridae</i>. The phage disrupted biofilm mass effectively when applied to 24 h old biofilms formed on the Foley silicon catheter and coverslip biofilm models. To study the effect of intact biofilm architecture on phage predation, the biofilms were disrupted. The phage reduced the viable cells by 0.6–1.0 order of magnitude after 24 h of incubation. Regrowth and intact bacterial cells were observed in the phage-treated planktonic culture and biofilms, respectively, which indicated the emergence of phage-resistant bacterial variants. The phage genome encoded an endolysin which might have a role in the disruption and inhibition of bacterial biofilms. Moreover, the genome lacked genes encoding toxins, virulence factors, antibiotic resistance, or lysogeny. Therefore, lytic phage 590B may be a good alternative to antibiotics and can be included in phage cocktails for the treatment of UTIs caused by biofilm-forming MDR and XDR UPEC strains.https://www.mdpi.com/2076-0817/11/12/1448phage therapyurinary tract infectionsphage cocktailmultidrug resistanceuropathogenic <i>Escherichia coli</i>
spellingShingle Naveen Chaudhary
Ravi Kumar Maurya
Dharminder Singh
Balvinder Mohan
Neelam Taneja
Genome Analysis and Antibiofilm Activity of Phage 590B against Multidrug-Resistant and Extensively Drug-Resistant Uropathogenic <i>Escherichia coli</i> Isolates, India
Pathogens
phage therapy
urinary tract infections
phage cocktail
multidrug resistance
uropathogenic <i>Escherichia coli</i>
title Genome Analysis and Antibiofilm Activity of Phage 590B against Multidrug-Resistant and Extensively Drug-Resistant Uropathogenic <i>Escherichia coli</i> Isolates, India
title_full Genome Analysis and Antibiofilm Activity of Phage 590B against Multidrug-Resistant and Extensively Drug-Resistant Uropathogenic <i>Escherichia coli</i> Isolates, India
title_fullStr Genome Analysis and Antibiofilm Activity of Phage 590B against Multidrug-Resistant and Extensively Drug-Resistant Uropathogenic <i>Escherichia coli</i> Isolates, India
title_full_unstemmed Genome Analysis and Antibiofilm Activity of Phage 590B against Multidrug-Resistant and Extensively Drug-Resistant Uropathogenic <i>Escherichia coli</i> Isolates, India
title_short Genome Analysis and Antibiofilm Activity of Phage 590B against Multidrug-Resistant and Extensively Drug-Resistant Uropathogenic <i>Escherichia coli</i> Isolates, India
title_sort genome analysis and antibiofilm activity of phage 590b against multidrug resistant and extensively drug resistant uropathogenic i escherichia coli i isolates india
topic phage therapy
urinary tract infections
phage cocktail
multidrug resistance
uropathogenic <i>Escherichia coli</i>
url https://www.mdpi.com/2076-0817/11/12/1448
work_keys_str_mv AT naveenchaudhary genomeanalysisandantibiofilmactivityofphage590bagainstmultidrugresistantandextensivelydrugresistanturopathogeniciescherichiacoliiisolatesindia
AT ravikumarmaurya genomeanalysisandantibiofilmactivityofphage590bagainstmultidrugresistantandextensivelydrugresistanturopathogeniciescherichiacoliiisolatesindia
AT dharmindersingh genomeanalysisandantibiofilmactivityofphage590bagainstmultidrugresistantandextensivelydrugresistanturopathogeniciescherichiacoliiisolatesindia
AT balvindermohan genomeanalysisandantibiofilmactivityofphage590bagainstmultidrugresistantandextensivelydrugresistanturopathogeniciescherichiacoliiisolatesindia
AT neelamtaneja genomeanalysisandantibiofilmactivityofphage590bagainstmultidrugresistantandextensivelydrugresistanturopathogeniciescherichiacoliiisolatesindia